Online chlamydia testing: an innovative approach that appeals to young people
Authors: Lewis J Marshall, Edwina A Jachimowicz, Lisa Bastian and Donna B Mak
Published online: 10 December 2012
In reply: Azzopardi and colleagues seem to equate “young” with “adolescent”. We defined “young” as less than 30 years of age; 84% of chlamydia notifications in Western Australia occur in this age group,1 and they comprised 71% of online chlamydia testing program (OLC) users.2 This group accesses the internet frequently, with about 90% of Australians under 35 years of age using the internet at least once a week.3
Any testing divorced from face-to-face care reduces health promotion opportunities. The WA Department of Health websites (http://www.getthefacts.health.wa.gov.au and http://www.couldihaveit. com.au) from which the OLC is accessed provide relevant health information and advise people with symptoms to seek medical care. In addition, all OLC users found to have a sexually transmitted infection are followed up by a sexual health nurse.2
We will continue to advocate for improved access for young people to sexual health services. As evidenced by the chlamydia prevalence of 18% among OLC users,2 the OLC is an effective addition to existing strategies aimed at increasing chlamydia testing among high-risk groups.
Competing interests
References
- Government of Western Australia Department of Health. The epidemiology of notifiable sexually transmitted infections and blood-borne viruses in Western Australia 2010. Perth: DoH, WA, 2011. 0_CBBBIAJF
- Kwan KS, Jachimowicz EA, Bastian L, et al. Online chlamydia testing: an innovative approach that appeals to young people. Med J Aust 2012; 197: 287-290. 0_i1142870
- Australian Communications and Media Authority. Communications report 2009–10 series. Report 1 — Australia in the digital economy: the shift to the online environment. Melbourne, ACMA, 2010. 0_i1142872
Hospital-Admitted Injection-Related Infections Among Incarcerated People Who Inject Drugs in Australia: A Retrospective Cohort Study
Andrew Palmer, Matthew Carter, Jeremy Yeo, Cecilia Shim, Jason Connor, Jeremy Hayllar, Gerald Holtmann, Naomi Moy, Elliott G. Playford, Naomi Runnegar, Paul J. Clark
The Live Attenuated Influenza Vaccine in Australia: An Additional Tool for Influenza Prevention
Cyra Patel, Alexis Pillsbury, Tran Nguyen, Xia Wang, Helen E. Quinn, Clayton K. Chiu, Allen C. Cheng, Katie L. Flanagan, Zhicheng Wang
Reflex Testing for Hepatitis D Infection: A Unique Opportunity to Reduce Hepatitis D-Related Chronic Liver Disease Deaths in Australia
Jessica Howell, Lauren Andersson, Miriam T. Levy, James O'Beirne, Leon Adams, Katharine Irvine, Avik Majumdar, Golo Ahlenstiel, Kathy Jackson, Krispin Hajkowicz, Joseph Doyle, Jane Davies, Sarah Cherian, Wayne Dimech, Alexander J. Thompson
Localised Herpes Simplex Following Midline Laparotomy
Jessica S. Bulluss, Paul Chee, Matthew J. Verheyden
West Nile virus Kunjin subtype in rural NSW
Emily Gibson, Megan Whitley, Peter Murray, Linda Hueston, Jane Bennett, Raguharan Kathiresu, David N Durrheim
Differentiated and simplified oral HIV pre‐exposure prophylaxis (PrEP) models hold the key to virtually eliminating HIV transmission in Australia by 2030
Tyson Arapali, Sarah Warzywoda, Anthony K J Smith, Curtis Chan, Timothy R Broady, Erin Sullivan, Catherine MacPhail, Mohamed A Hammoud, Alexander Dowell‐Day, Benjamin R Bavinton